-
1
-
-
84855967858
-
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia
-
Abdelhamid, E., Preudhomme, C., Helevaut, N., Nibourel, O., Gardin, C., Rousselot, P., Castaigne, S., Gruson, B., Berthon, C., Soua, Z. & Renneville, A. (2012) Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Leukemia Research, 36, 316-323.
-
(2012)
Leukemia Research
, vol.36
, pp. 316-323
-
-
Abdelhamid, E.1
Preudhomme, C.2
Helevaut, N.3
Nibourel, O.4
Gardin, C.5
Rousselot, P.6
Castaigne, S.7
Gruson, B.8
Berthon, C.9
Soua, Z.10
Renneville, A.11
-
2
-
-
0033556427
-
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia
-
Aggerholm, A., Guldberg, P., Hokland, M. & Hokland, P. (1999) Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Research, 59, 436-441.
-
(1999)
Cancer Research
, vol.59
, pp. 436-441
-
-
Aggerholm, A.1
Guldberg, P.2
Hokland, M.3
Hokland, P.4
-
3
-
-
58549114892
-
The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia
-
Al-Mawali, A., Gillis, D. & Lewis, I. (2009) The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia. American Journal of Clinical Pathology, 131, 16-26.
-
(2009)
American Journal of Clinical Pathology
, vol.131
, pp. 16-26
-
-
Al-Mawali, A.1
Gillis, D.2
Lewis, I.3
-
4
-
-
33646404606
-
Age and acute myeloid leukemia
-
Appelbaum, F.R., Gundacker, H., Head, D.R., Slovak, M.L., Willman, C.L., Godwin, J.E., Anderson, J.E. & Petersdorf, S.H. (2006) Age and acute myeloid leukemia. Blood, 107, 3481-3485.
-
(2006)
Blood
, vol.107
, pp. 3481-3485
-
-
Appelbaum, F.R.1
Gundacker, H.2
Head, D.R.3
Slovak, M.L.4
Willman, C.L.5
Godwin, J.E.6
Anderson, J.E.7
Petersdorf, S.H.8
-
5
-
-
33750087521
-
The MLL partial tandem duplication in acute myeloid leukaemia
-
Basecke, J., Whelan, J.T., Griesinger, F. & Bertrand, F.E. (2006) The MLL partial tandem duplication in acute myeloid leukaemia. British Journal of Haematology, 135, 438-449.
-
(2006)
British Journal of Haematology
, vol.135
, pp. 438-449
-
-
Basecke, J.1
Whelan, J.T.2
Griesinger, F.3
Bertrand, F.E.4
-
6
-
-
79954450713
-
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
-
Béné, M.C., Nebe, T., Bettelheim, P., Buldini, B., Bumbea, H., Kern, W., Lacombe, F., Lemez, P., Marinov, I., Matutes, E., Maynadié, M., Oelschlagel, U., Orfao, A., Schabath, R., Solenthaler, M., Tschurtschenthaler, G., Vladareanu, A.M., Zini, G., Faure, G.C. & Porwit, A. (2011) Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia, 25, 567-574.
-
(2011)
Leukemia
, vol.25
, pp. 567-574
-
-
Béné, M.C.1
Nebe, T.2
Bettelheim, P.3
Buldini, B.4
Bumbea, H.5
Kern, W.6
Lacombe, F.7
Lemez, P.8
Marinov, I.9
Matutes, E.10
Maynadié, M.11
Oelschlagel, U.12
Orfao, A.13
Schabath, R.14
Solenthaler, M.15
Tschurtschenthaler, G.16
Vladareanu, A.M.17
Zini, G.18
Faure, G.C.19
Porwit, A.20
more..
-
7
-
-
84899054083
-
Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome
-
Bernal, T., Diez-Campelo, M., Godoy, V., Rojas, S., Colado, E., Alcoceba, M., González, M., Vidriales, B., Sánchez-Guijo, F.M., López-Corral, L., Luño, E. & Del Cañizo, C. (2014) Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome. Leukemia Research, 38, 551-556.
-
(2014)
Leukemia Research
, vol.38
, pp. 551-556
-
-
Bernal, T.1
Diez-Campelo, M.2
Godoy, V.3
Rojas, S.4
Colado, E.5
Alcoceba, M.6
González, M.7
Vidriales, B.8
Sánchez-Guijo, F.M.9
López-Corral, L.10
Luño, E.11
Del Cañizo, C.12
-
8
-
-
33744487375
-
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
-
Boissel, N., Leroy, H., Brethon, B., Philippe, N., de Botton, S., Auvrignon, A., Raffoux, E., Leblanc, T., Thomas, X., Hermine, O., Quesnel, B., Baruchel, A., Leverger, G., Dombret, H. & Preudhomme, C.; Acute Leukemia French Association (ALFA) Leucémies Aiguës Myéloblastiques de l'Enfant (LAME) Cooperative Groups (2006) Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). Leukemia, 20, 965-970.
-
(2006)
Leukemia
, vol.20
, pp. 965-970
-
-
Boissel, N.1
Leroy, H.2
Brethon, B.3
Philippe, N.4
de Botton, S.5
Auvrignon, A.6
Raffoux, E.7
Leblanc, T.8
Thomas, X.9
Hermine, O.10
Quesnel, B.11
Baruchel, A.12
Leverger, G.13
Dombret, H.14
Preudhomme, C.15
-
9
-
-
74049145703
-
Monitoring of minimal residual disease in acute myeloid leukemia
-
Buccisano, F., Maurillo, L., Spagnoli, A., Del Principe, M.I., Ceresoli, E., Lo-Coco, F., Arcese, W., Amadori, S. & Venditti, A. (2009) Monitoring of minimal residual disease in acute myeloid leukemia. Current Opinion in Oncology, 21, 582-588.
-
(2009)
Current Opinion in Oncology
, vol.21
, pp. 582-588
-
-
Buccisano, F.1
Maurillo, L.2
Spagnoli, A.3
Del Principe, M.I.4
Ceresoli, E.5
Lo-Coco, F.6
Arcese, W.7
Amadori, S.8
Venditti, A.9
-
10
-
-
84855838173
-
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
-
Buccisano, F., Maurillo, L., Del Principe, M.I., Del Poeta, G., Sconocchia, G., Lo-Coco, F., Arcese, W., Amadori, S. & Venditti, A. (2012) Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood, 119, 332-341.
-
(2012)
Blood
, vol.119
, pp. 332-341
-
-
Buccisano, F.1
Maurillo, L.2
Del Principe, M.I.3
Del Poeta, G.4
Sconocchia, G.5
Lo-Coco, F.6
Arcese, W.7
Amadori, S.8
Venditti, A.9
-
11
-
-
79952086942
-
Therapeutic advances in acute myeloid leukemia
-
Burnett, A., Wetzler, M. & Lowenberg, B. (2011) Therapeutic advances in acute myeloid leukemia. Journal of Clinical Oncology, 29, 487-494.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 487-494
-
-
Burnett, A.1
Wetzler, M.2
Lowenberg, B.3
-
12
-
-
84879841453
-
Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation
-
Campana, D. & Leung, W. (2013) Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation. British Journal of Haematology, 162, 147-161.
-
(2013)
British Journal of Haematology
, vol.162
, pp. 147-161
-
-
Campana, D.1
Leung, W.2
-
13
-
-
84878372012
-
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
-
Cancer Genome Atlas Research Network (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England Journal of Medicine, 368, 2059-2074.
-
(2013)
The New England Journal of Medicine
, vol.368
, pp. 2059-2074
-
-
-
14
-
-
77949453508
-
Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology
-
ten Cate, B., de Bruyn, M., Wei, Y., Bremer, E. & Helfrich, W. (2010) Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology. Current Drug Targets, 11, 95-110.
-
(2010)
Current Drug Targets
, vol.11
, pp. 95-110
-
-
ten Cate, B.1
de Bruyn, M.2
Wei, Y.3
Bremer, E.4
Helfrich, W.5
-
15
-
-
79959323833
-
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation
-
Chen, Y., Cortes, J., Estrov, Z., Faderl, S., Qiao, W., Abruzzo, L., Garcia-Manero, G., Pierce, S., Huang, X., Kebriaei, P., Kadia, T., De Lima, M., Kantarjian, H. & Ravandi, F. (2011) Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation. Journal of Clinical Oncology, 29, 2507-2513.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 2507-2513
-
-
Chen, Y.1
Cortes, J.2
Estrov, Z.3
Faderl, S.4
Qiao, W.5
Abruzzo, L.6
Garcia-Manero, G.7
Pierce, S.8
Huang, X.9
Kebriaei, P.10
Kadia, T.11
De Lima, M.12
Kantarjian, H.13
Ravandi, F.14
-
16
-
-
1542753559
-
Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
-
Cheson, B.D. (2003) Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. Journal of Clinical Oncology, 21, 4642-4649.
-
(2003)
Journal of Clinical Oncology
, vol.21
, pp. 4642-4649
-
-
Cheson, B.D.1
-
17
-
-
80053620171
-
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
-
Chou, W.-C., Chou, S.-C., Liu, C.-Y., Chen, C.-Y., Hou, H.-A., Kuo, Y.-Y., Lee, M.-C., Ko, B.-S., Tang, J.-L., Yao, M., Tsay, W., Wu, S.-J., Huang, S.-Y., Hsu, S.-C., Chen, Y.-C., Chang, Y.-C., Kuo, Y.-Y., Kuo, K.-T., Lee, F.-Y., Liu, M.-C., Liu, C.-W., Tseng, M.-H., Huang, C.-F. & Tien, H.-F. (2011) TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. Blood, 118, 3803-3810.
-
(2011)
Blood
, vol.118
, pp. 3803-3810
-
-
Chou, W.-C.1
Chou, S.-C.2
Liu, C.-Y.3
Chen, C.-Y.4
Hou, H.-A.5
Kuo, Y.-Y.6
Lee, M.-C.7
Ko, B.-S.8
Tang, J.-L.9
Yao, M.10
Tsay, W.11
Wu, S.-J.12
Huang, S.-Y.13
Hsu, S.-C.14
Chen, Y.-C.15
Chang, Y.-C.16
Kuo, Y.-Y.17
Kuo, K.-T.18
Lee, F.-Y.19
Liu, M.-C.20
Liu, C.-W.21
Tseng, M.-H.22
Huang, C.-F.23
Tien, H.-F.24
more..
-
18
-
-
84873341730
-
Should evaluation for minimal residual disease be routine in acute myeloid leukemia?
-
Coustan-Smith, E. & Campana, D. (2013) Should evaluation for minimal residual disease be routine in acute myeloid leukemia? Current Opinion in Hematology, 20, 86-92.
-
(2013)
Current Opinion in Hematology
, vol.20
, pp. 86-92
-
-
Coustan-Smith, E.1
Campana, D.2
-
19
-
-
43249130717
-
Flow cytometric immunophenotyping for hematologic neoplasms
-
Craig, F. & Foon, K. (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood, 111, 3941-3967.
-
(2008)
Blood
, vol.111
, pp. 3941-3967
-
-
Craig, F.1
Foon, K.2
-
20
-
-
79955973367
-
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
-
Damm, F., Heuser, M., Morgan, M., Wagner, K., Görlich, K., Grosshennig, A., Hamwi, I., Thol, F., Surdziel, E., Fiedler, W., Lübbert, M., Kanz, L., Reuter, C., Heil, G., Delwel, R., Löwenberg, B., Valk, P.J.M., Krauter, J. & Ganser, A. (2011) Integrative prognostic risk score in acute myeloid leukemia with normal karyotype. Blood, 117, 4561-4568.
-
(2011)
Blood
, vol.117
, pp. 4561-4568
-
-
Damm, F.1
Heuser, M.2
Morgan, M.3
Wagner, K.4
Görlich, K.5
Grosshennig, A.6
Hamwi, I.7
Thol, F.8
Surdziel, E.9
Fiedler, W.10
Lübbert, M.11
Kanz, L.12
Reuter, C.13
Heil, G.14
Delwel, R.15
Löwenberg, B.16
Valk, P.J.M.17
Krauter, J.18
Ganser, A.19
-
21
-
-
84856889380
-
Beyond morphology: minimal residual disease detection in acute myeloid leukemia
-
Dinardo, C.D. & Luger, S.M. (2012) Beyond morphology: minimal residual disease detection in acute myeloid leukemia. Current Opinion in Hematology, 19, 82-88.
-
(2012)
Current Opinion in Hematology
, vol.19
, pp. 82-88
-
-
Dinardo, C.D.1
Luger, S.M.2
-
22
-
-
84862776906
-
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
-
Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., Ritchey, J.K., Young, M.A., Lamprecht, T., McLellan, M.D., McMichael, J.F., Wallis, J.W., Lu, C., Shen, D., Harris, C.C., Dooling, D.J., Fulton, R.S., Fulton, L.L., Chen, K., Schmidt, H., Kalicki-Veizer, J., Magrini, V.J., Cook, L., McGrath, S.D., Vickery, T.V., Wendl, M.C., Heath, S., Watson, M.A., Link, D.C., Tomasson, M.H., Shannon, W.D., Payton, J.E., Kulkarni, S., Westervelt, P., Walter, M.J., Graubert, T.A., Mardis, E.R., Wilson, R.K. & DiPersio, J.F. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature, 481, 506-510.
-
(2012)
Nature
, vol.481
, pp. 506-510
-
-
Ding, L.1
Ley, T.J.2
Larson, D.E.3
Miller, C.A.4
Koboldt, D.C.5
Welch, J.S.6
Ritchey, J.K.7
Young, M.A.8
Lamprecht, T.9
McLellan, M.D.10
McMichael, J.F.11
Wallis, J.W.12
Lu, C.13
Shen, D.14
Harris, C.C.15
Dooling, D.J.16
Fulton, R.S.17
Fulton, L.L.18
Chen, K.19
Schmidt, H.20
Kalicki-Veizer, J.21
Magrini, V.J.22
Cook, L.23
McGrath, S.D.24
Vickery, T.V.25
Wendl, M.C.26
Heath, S.27
Watson, M.A.28
Link, D.C.29
Tomasson, M.H.30
Shannon, W.D.31
Payton, J.E.32
Kulkarni, S.33
Westervelt, P.34
Walter, M.J.35
Graubert, T.A.36
Mardis, E.R.37
Wilson, R.K.38
DiPersio, J.F.39
more..
-
23
-
-
84880602370
-
Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities
-
Djunic, I., Suvajdzic-Vukovic, N., Virijevic, M., Novkovic, A., Colovic, N., Vidovic, A. & Tomin, D. (2013) Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities. Medical Oncology, 30, 394.
-
(2013)
Medical Oncology
, vol.30
, pp. 394
-
-
Djunic, I.1
Suvajdzic-Vukovic, N.2
Virijevic, M.3
Novkovic, A.4
Colovic, N.5
Vidovic, A.6
Tomin, D.7
-
24
-
-
0036682174
-
Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm
-
Döhner, K., Tobis, K., Ulrich, R., Fröhling, S., Benner, A., Schlenk, R.F. & Döhner, H. (2002) Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. Journal of Clinical Oncology, 20, 3254-3261.
-
(2002)
Journal of Clinical Oncology
, vol.20
, pp. 3254-3261
-
-
Döhner, K.1
Tobis, K.2
Ulrich, R.3
Fröhling, S.4
Benner, A.5
Schlenk, R.F.6
Döhner, H.7
-
25
-
-
77449159028
-
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
-
Döhner, H., Estey, E.H., Amadori, S., Appelbaum, F.R., Büchner, T., Burnett, A.K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R.A., Lo-Coco, F., Naoe, T., Niederwieser, D., Ossenkoppele, G.J., Sanz, M.A., Sierra, J., Tallman, M.S., Löwenberg, B. & Bloomfield, C.D.; European LeukemiaNet (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood, 115, 453-474.
-
(2010)
Blood
, vol.115
, pp. 453-474
-
-
Döhner, H.1
Estey, E.H.2
Amadori, S.3
Appelbaum, F.R.4
Büchner, T.5
Burnett, A.K.6
Dombret, H.7
Fenaux, P.8
Grimwade, D.9
Larson, R.A.10
Lo-Coco, F.11
Naoe, T.12
Niederwieser, D.13
Ossenkoppele, G.J.14
Sanz, M.A.15
Sierra, J.16
Tallman, M.S.17
Löwenberg, B.18
Bloomfield, C.D.19
-
26
-
-
79955952683
-
Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in FA AML
-
Du, W., Li, X., Sipple, J. & Pang, Q. (2011) Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in FA AML. Blood, 117, 4243-4252.
-
(2011)
Blood
, vol.117
, pp. 4243-4252
-
-
Du, W.1
Li, X.2
Sipple, J.3
Pang, Q.4
-
28
-
-
84055218304
-
Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
-
Estey, E.H. (2012) Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. American Journal of Hematology, 87, 89-99.
-
(2012)
American Journal of Hematology
, vol.87
, pp. 89-99
-
-
Estey, E.H.1
-
29
-
-
84875632298
-
Acute myeloid leukemia: 2013 update on risk-stratification and management
-
Estey, E.H. (2013) Acute myeloid leukemia: 2013 update on risk-stratification and management. American Journal of Hematology, 88, 318-327.
-
(2013)
American Journal of Hematology
, vol.88
, pp. 318-327
-
-
Estey, E.H.1
-
30
-
-
74049158596
-
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives
-
Falini, B., Sportoletti, P. & Martelli, M.P. (2009) Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. Current Opinion in Oncology, 21, 573-581.
-
(2009)
Current Opinion in Oncology
, vol.21
, pp. 573-581
-
-
Falini, B.1
Sportoletti, P.2
Martelli, M.P.3
-
31
-
-
84898051374
-
The role of different genetic subtypes of CEBPA mutated AML
-
Fasan, A., Haferlach, C., Alpermann, T., Jeromin, S., Grossmann, V., Eder, C., Weissmann, S., Dicker, F., Kohlmann, A., Schindela, S., Kern, W., Haferlach, T. & Schnittger, S. (2013) The role of different genetic subtypes of CEBPA mutated AML. Leukemia, 28, 794-803.
-
(2013)
Leukemia
, vol.28
, pp. 794-803
-
-
Fasan, A.1
Haferlach, C.2
Alpermann, T.3
Jeromin, S.4
Grossmann, V.5
Eder, C.6
Weissmann, S.7
Dicker, F.8
Kohlmann, A.9
Schindela, S.10
Kern, W.11
Haferlach, T.12
Schnittger, S.13
-
32
-
-
66549116716
-
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group
-
Gaidzik, V.I., Schlenk, R.F., Moschny, S., Becker, A., Bullinger, L., Corbacioglu, A., Krauter, J., Schlegelberger, B., Ganser, A., Döhner, H. & Döhner, K.; German-Austrian AML Study Group (2009) Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. Blood, 113, 4505-4511.
-
(2009)
Blood
, vol.113
, pp. 4505-4511
-
-
Gaidzik, V.I.1
Schlenk, R.F.2
Moschny, S.3
Becker, A.4
Bullinger, L.5
Corbacioglu, A.6
Krauter, J.7
Schlegelberger, B.8
Ganser, A.9
Döhner, H.10
Döhner, K.11
-
33
-
-
84881051116
-
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
-
Gaidzik, V.I., Schlenk, R.F., Paschka, P., Stölzle, A., Späth, D., Kuendgen, A., vonLilienfeld-Toal, M., Brugger, W., Derigs, H.G., Kremers, S., Greil, R., Raghavachar, A., Ringhoffer, M., Salih, H.R., Wattad, M., Kirchen, H.G., Runde, V., Heil, G., Petzer, A.L., Girschikofsky, M., Heuser, M., Kayser, S., Goehring, G., Teleanu, M.-V., Schlegelberger, B., Ganser, A., Krauter, J., Bullinger, L., Döhner, H. & Döhner, K. (2013) Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). Blood, 121, 4769-4777.
-
(2013)
Blood
, vol.121
, pp. 4769-4777
-
-
Gaidzik, V.I.1
Schlenk, R.F.2
Paschka, P.3
Stölzle, A.4
Späth, D.5
Kuendgen, A.6
von Lilienfeld-Toal, M.7
Brugger, W.8
Derigs, H.G.9
Kremers, S.10
Greil, R.11
Raghavachar, A.12
Ringhoffer, M.13
Salih, H.R.14
Wattad, M.15
Kirchen, H.G.16
Runde, V.17
Heil, G.18
Petzer, A.L.19
Girschikofsky, M.20
Heuser, M.21
Kayser, S.22
Goehring, G.23
Teleanu, M.-V.24
Schlegelberger, B.25
Ganser, A.26
Krauter, J.27
Bullinger, L.28
Döhner, H.29
Döhner, K.30
more..
-
34
-
-
66849124925
-
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia
-
Gelsi-Boyer, V., Trouplin, V., Adélaïde, J., Bonansea, J., Cervera, N., Carbuccia, N., Lagarde, A., Prebet, T., Nezri, M., Sainty, D., Olschwang, S., Xerri, L., Chaffanet, M., Mozziconacci, M.-J., Vey, N. & Birnbaum, D. (2009) Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. British Journal of Haematology, 145, 788-800.
-
(2009)
British Journal of Haematology
, vol.145
, pp. 788-800
-
-
Gelsi-Boyer, V.1
Trouplin, V.2
Adélaïde, J.3
Bonansea, J.4
Cervera, N.5
Carbuccia, N.6
Lagarde, A.7
Prebet, T.8
Nezri, M.9
Sainty, D.10
Olschwang, S.11
Xerri, L.12
Chaffanet, M.13
Mozziconacci, M.-J.14
Vey, N.15
Birnbaum, D.16
-
35
-
-
84859854912
-
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia
-
Gerber, J.M., Smith, B.D., Ngwang, B., Zhang, H., Vala, M.S., Morsberger, L., Galkin, S., Collector, M.I., Perkins, B., Levis, M.J., Griffin, C.A., Sharkis, S.J., Borowitz, M.J., Karp, J.E. & Jones, R.J. (2012) A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood, 119, 3571-3577.
-
(2012)
Blood
, vol.119
, pp. 3571-3577
-
-
Gerber, J.M.1
Smith, B.D.2
Ngwang, B.3
Zhang, H.4
Vala, M.S.5
Morsberger, L.6
Galkin, S.7
Collector, M.I.8
Perkins, B.9
Levis, M.J.10
Griffin, C.A.11
Sharkis, S.J.12
Borowitz, M.J.13
Karp, J.E.14
Jones, R.J.15
-
36
-
-
33846433493
-
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia
-
Giles, F.J., Borthakur, G., Ravandi, F., Faderl, S., Verstovsek, S., Thomas, D., Wierda, W., Ferrajoli, A., Kornblau, S., Pierce, S., Albitar, M., Cortes, J. & Kantarjian, H. (2007) The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia. British Journal of Haematology, 136, 624-627.
-
(2007)
British Journal of Haematology
, vol.136
, pp. 624-627
-
-
Giles, F.J.1
Borthakur, G.2
Ravandi, F.3
Faderl, S.4
Verstovsek, S.5
Thomas, D.6
Wierda, W.7
Ferrajoli, A.8
Kornblau, S.9
Pierce, S.10
Albitar, M.11
Cortes, J.12
Kantarjian, H.13
-
38
-
-
77954921625
-
Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations
-
Green, C.L., Koo, K.K., Hills, R.K., Burnett, A.K., Linch, D.C. & Gale, R.E. (2010) Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. Journal of Clinical Oncology, 28, 2739-2747.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 2739-2747
-
-
Green, C.L.1
Koo, K.K.2
Hills, R.K.3
Burnett, A.K.4
Linch, D.C.5
Gale, R.E.6
-
39
-
-
0034758836
-
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
-
Grimwade, D. (2001) The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia. Best Practice & Research Clinical Haematology, 14, 497-529.
-
(2001)
Best Practice & Research Clinical Haematology
, vol.14
, pp. 497-529
-
-
Grimwade, D.1
-
40
-
-
68949137224
-
Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy
-
Grimwade, D., Jovanovic, J.V., Hills, R.K., Nugent, E.A., Patel, Y., Flora, R., Diverio, D., Jones, K., Aslett, H., Batson, E., Rennie, K., Angell, R., Clark, R.E., Solomon, E., Lo-Coco, F., Wheatley, K. & Burnett, A.K. (2009) Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. Journal of Clinical Oncology, 27, 3650-3658.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 3650-3658
-
-
Grimwade, D.1
Jovanovic, J.V.2
Hills, R.K.3
Nugent, E.A.4
Patel, Y.5
Flora, R.6
Diverio, D.7
Jones, K.8
Aslett, H.9
Batson, E.10
Rennie, K.11
Angell, R.12
Clark, R.E.13
Solomon, E.14
Lo-Coco, F.15
Wheatley, K.16
Burnett, A.K.17
-
41
-
-
77955914238
-
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
-
Grimwade, D., Hills, R.K., Moorman, A.V., Walker, H., Chatters, S., Goldstone, A.H., Wheatley, K., Harrison, C.J. & Burnett, A.K.; National Cancer Research Institute Adult Leukaemia Working Group (2010a) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 116, 354-365.
-
(2010)
Blood
, vol.116
, pp. 354-365
-
-
Grimwade, D.1
Hills, R.K.2
Moorman, A.V.3
Walker, H.4
Chatters, S.5
Goldstone, A.H.6
Wheatley, K.7
Harrison, C.J.8
Burnett, A.K.9
-
42
-
-
77958468721
-
Assessment of minimal residual disease in acute myeloid leukemia
-
Grimwade, D., Vyas, P. & Freeman, S. (2010b) Assessment of minimal residual disease in acute myeloid leukemia. Current Opinion in Oncology, 22, 656-663.
-
(2010)
Current Opinion in Oncology
, vol.22
, pp. 656-663
-
-
Grimwade, D.1
Vyas, P.2
Freeman, S.3
-
43
-
-
84867806184
-
A novel hierarchical prognostic model of AML solely based on molecular mutations
-
Grossmann, V., Schnittger, S., Kohlmann, A., Eder, C., Roller, A., Dicker, F., Schmid, C., Wendtner, C.-M., Staib, P., Serve, H., Kreuzer, K.-A., Kern, W., Haferlach, T. & Haferlach, C. (2012) A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood, 120, 2963-2972.
-
(2012)
Blood
, vol.120
, pp. 2963-2972
-
-
Grossmann, V.1
Schnittger, S.2
Kohlmann, A.3
Eder, C.4
Roller, A.5
Dicker, F.6
Schmid, C.7
Wendtner, C.-M.8
Staib, P.9
Serve, H.10
Kreuzer, K.-A.11
Kern, W.12
Haferlach, T.13
Haferlach, C.14
-
44
-
-
84881663530
-
High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group
-
Ho, P.A., Alonzo, T.A., Gerbing, R.B., Pollard, J.A., Hirsch, B., Raimondi, S.C., Cooper, T., Gamis, A.S. & Meshinchi, S. (2013) High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group. British Journal of Haematology, 162, 670-677.
-
(2013)
British Journal of Haematology
, vol.162
, pp. 670-677
-
-
Ho, P.A.1
Alonzo, T.A.2
Gerbing, R.B.3
Pollard, J.A.4
Hirsch, B.5
Raimondi, S.C.6
Cooper, T.7
Gamis, A.S.8
Meshinchi, S.9
-
45
-
-
84865128557
-
Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission-methodologies in relation to their clinical situation
-
Hokland, P., Ommen, H.B., Nyvold, C.G. & Roug, A.S. (2012) Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission-methodologies in relation to their clinical situation. British Journal of Haematology, 158, 569-580.
-
(2012)
British Journal of Haematology
, vol.158
, pp. 569-580
-
-
Hokland, P.1
Ommen, H.B.2
Nyvold, C.G.3
Roug, A.S.4
-
46
-
-
34547415968
-
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
-
Hosen, N., Park, C.Y., Tatsumi, N., Oji, Y., Sugiyama, H., Gramatzki, M., Krensky, A.M. & Weissman, I.L. (2007) CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 104, 11008-11013.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, pp. 11008-11013
-
-
Hosen, N.1
Park, C.Y.2
Tatsumi, N.3
Oji, Y.4
Sugiyama, H.5
Gramatzki, M.6
Krensky, A.M.7
Weissman, I.L.8
-
47
-
-
77954671159
-
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system
-
Hou, H.-A., Huang, T.-C., Lin, L.-I., Liu, C.-Y., Chen, C.-Y., Chou, W.-C., Tang, J.-L., Tseng, M.-H., Huang, C.-F., Chiang, Y.-C., Lee, F.-Y., Liu, M.-C., Yao, M., Huang, S.-Y., Ko, B.-S., Hsu, S.-C., Wu, S.-J., Tsay, W., Chen, Y.-C. & Tien, H.-F. (2010) WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system. Blood, 115, 5222-5231.
-
(2010)
Blood
, vol.115
, pp. 5222-5231
-
-
Hou, H.-A.1
Huang, T.-C.2
Lin, L.-I.3
Liu, C.-Y.4
Chen, C.-Y.5
Chou, W.-C.6
Tang, J.-L.7
Tseng, M.-H.8
Huang, C.-F.9
Chiang, Y.-C.10
Lee, F.-Y.11
Liu, M.-C.12
Yao, M.13
Huang, S.-Y.14
Ko, B.-S.15
Hsu, S.-C.16
Wu, S.-J.17
Tsay, W.18
Chen, Y.-C.19
Tien, H.-F.20
more..
-
49
-
-
84870720777
-
Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia
-
How, J., Sykes, J., Gupta, V., Yee, K.W.L., Schimmer, A.D., Schuh, A.C., Minden, M.D., Kamel-Reid, S. & Brandwein, J.M. (2012) Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia. Cancer, 118, 6110-6117.
-
(2012)
Cancer
, vol.118
, pp. 6110-6117
-
-
How, J.1
Sykes, J.2
Gupta, V.3
Yee, K.W.L.4
Schimmer, A.D.5
Schuh, A.C.6
Minden, M.D.7
Kamel-Reid, S.8
Brandwein, J.M.9
-
50
-
-
67650646082
-
CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis
-
Jaiswal, S., Jamieson, C.H.M., Pang, W.W., Park, C.Y., Chao, M.P., Majeti, R., Traver, D., van Rooijen, N. & Weissman, I.L. (2009) CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell, 138, 271-285.
-
(2009)
Cell
, vol.138
, pp. 271-285
-
-
Jaiswal, S.1
Jamieson, C.H.M.2
Pang, W.W.3
Park, C.Y.4
Chao, M.P.5
Majeti, R.6
Traver, D.7
van Rooijen, N.8
Weissman, I.L.9
-
51
-
-
79953223346
-
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
-
Jan, M., Chao, M.P., Cha, A.C., Alizadeh, A.A., Gentles, A.J., Weissman, I.L. & Majeti, R. (2011) Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proceedings of the National Academy of Sciences of the United States of America, 108, 5009-5014.
-
(2011)
Proceedings of the National Academy of Sciences of the United States of America
, vol.108
, pp. 5009-5014
-
-
Jan, M.1
Chao, M.P.2
Cha, A.C.3
Alizadeh, A.A.4
Gentles, A.J.5
Weissman, I.L.6
Majeti, R.7
-
52
-
-
33749515476
-
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
-
Jin, L., Hope, K.J., Zhai, Q., Smadja-Joffe, F. & Dick, J.E. (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Medicine, 12, 1167-1174.
-
(2006)
Nature Medicine
, vol.12
, pp. 1167-1174
-
-
Jin, L.1
Hope, K.J.2
Zhai, Q.3
Smadja-Joffe, F.4
Dick, J.E.5
-
53
-
-
67649200331
-
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells
-
Jin, L., Lee, E., Ramshaw, H., Busfield, S., Peoppl, A., Wilkinson, L., Guthridge, M., Thomas, D., Barry, E., Boyd, A., Gearing, D., Vairo, G., Lopez, A., Dick, J. & Lock, R. (2009) Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell, 5, 31-42.
-
(2009)
Cell Stem Cell
, vol.5
, pp. 31-42
-
-
Jin, L.1
Lee, E.2
Ramshaw, H.3
Busfield, S.4
Peoppl, A.5
Wilkinson, L.6
Guthridge, M.7
Thomas, D.8
Barry, E.9
Boyd, A.10
Gearing, D.11
Vairo, G.12
Lopez, A.13
Dick, J.14
Lock, R.15
-
54
-
-
84877930402
-
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
-
Jourdan, E., Boissel, N., Chevret, S., Delabesse, E., Renneville, A., Cornillet, P., Blanchet, O., Cayuela, J.-M., Recher, C., Raffoux, E., Delaunay, J., Pigneux, A., Bulabois, C.-E., Berthon, C., Pautas, C., Vey, N., Lioure, B., Thomas, X., Luquet, I., Terre, C., Guardiola, P., Béné, M.C., Preudhomme, C., Ifrah, N. & Dombret, H.; French AML Intergroup (2013) Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia. Blood, 121, 2213-2223.
-
(2013)
Blood
, vol.121
, pp. 2213-2223
-
-
Jourdan, E.1
Boissel, N.2
Chevret, S.3
Delabesse, E.4
Renneville, A.5
Cornillet, P.6
Blanchet, O.7
Cayuela, J.-M.8
Recher, C.9
Raffoux, E.10
Delaunay, J.11
Pigneux, A.12
Bulabois, C.-E.13
Berthon, C.14
Pautas, C.15
Vey, N.16
Lioure, B.17
Thomas, X.18
Luquet, I.19
Terre, C.20
Guardiola, P.21
Béné, M.C.22
Preudhomme, C.23
Ifrah, N.24
Dombret, H.25
more..
-
55
-
-
66149148673
-
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
-
Juliusson, G., Antunovic, P., Derolf, A., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A. & Höglund, M. (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood, 113, 4179-4187.
-
(2009)
Blood
, vol.113
, pp. 4179-4187
-
-
Juliusson, G.1
Antunovic, P.2
Derolf, A.3
Lehmann, S.4
Möllgård, L.5
Stockelberg, D.6
Tidefelt, U.7
Wahlin, A.8
Höglund, M.9
-
56
-
-
78649521002
-
The role of multiparameter flow cytometry for disease monitoring in AML
-
Kern, W., Bacher, U., Haferlach, C., Schnittger, S. & Haferlach, T. (2010) The role of multiparameter flow cytometry for disease monitoring in AML. Best Practice & Research Clinical Haematology, 23, 379-390.
-
(2010)
Best Practice & Research Clinical Haematology
, vol.23
, pp. 379-390
-
-
Kern, W.1
Bacher, U.2
Haferlach, C.3
Schnittger, S.4
Haferlach, T.5
-
57
-
-
84905686309
-
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
-
Kihara, R., Nagata, Y., Kiyoi, H., Kato, T., Yamamoto, E., Suzuki, K., Chen, F., Asou, N., Ohtake, S., Miyawaki, S., Miyazaki, Y., Sakura, T., Ozawa, Y., Usui, N., Kanamori, H., Kiguchi, T., Imai, K., Uike, N., Kimura, F., Kitamura, K., Nakaseko, C., Onizuka, M., Takeshita, A., Ishida, F., Suzushima, H., Kato, Y., Miwa, H., Shiraishi, Y., Chiba, K., Tanaka, H., Miyano, S., Ogawa, S. & Naoe, T. (2014) Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients. Leukemia, doi: 10.1038/leu.2014.55.
-
(2014)
Leukemia
-
-
Kihara, R.1
Nagata, Y.2
Kiyoi, H.3
Kato, T.4
Yamamoto, E.5
Suzuki, K.6
Chen, F.7
Asou, N.8
Ohtake, S.9
Miyawaki, S.10
Miyazaki, Y.11
Sakura, T.12
Ozawa, Y.13
Usui, N.14
Kanamori, H.15
Kiguchi, T.16
Imai, K.17
Uike, N.18
Kimura, F.19
Kitamura, K.20
Nakaseko, C.21
Onizuka, M.22
Takeshita, A.23
Ishida, F.24
Suzushima, H.25
Kato, Y.26
Miwa, H.27
Shiraishi, Y.28
Chiba, K.29
Tanaka, H.30
Miyano, S.31
Ogawa, S.32
Naoe, T.33
more..
-
58
-
-
84874735262
-
Next-generation sequencing - feasibility and practicality in haematology
-
Kohlmann, A., Grossmann, V., Nadarajah, N. & Haferlach, T. (2013) Next-generation sequencing - feasibility and practicality in haematology. British Journal of Haematology, 160, 736-753.
-
(2013)
British Journal of Haematology
, vol.160
, pp. 736-753
-
-
Kohlmann, A.1
Grossmann, V.2
Nadarajah, N.3
Haferlach, T.4
-
59
-
-
84904871973
-
Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing
-
Kohlmann, A., Bacher, U., Schnittger, S. & Haferlach, T. (2014) Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing. Leukemia & Lymphoma, 55, 1725-1734.
-
(2014)
Leukemia & Lymphoma
, vol.55
, pp. 1725-1734
-
-
Kohlmann, A.1
Bacher, U.2
Schnittger, S.3
Haferlach, T.4
-
60
-
-
70349335957
-
Monoclonal antibodies against IREM-1: potential for targeted therapy of AML
-
Korver, W., Zhao, X., Singh, S., Pardoux, C., Zhao, J., Guzman, M.L., Sen, S., Yonkovich, S., Liu, S., Zhan, X., Tomasevic, N., Zhou, C., Gros, D., Jordan, C.T., Gotlib, J., Hsi, E.D. & Abo, A. (2009) Monoclonal antibodies against IREM-1: potential for targeted therapy of AML. Leukemia, 23, 1587-1597.
-
(2009)
Leukemia
, vol.23
, pp. 1587-1597
-
-
Korver, W.1
Zhao, X.2
Singh, S.3
Pardoux, C.4
Zhao, J.5
Guzman, M.L.6
Sen, S.7
Yonkovich, S.8
Liu, S.9
Zhan, X.10
Tomasevic, N.11
Zhou, C.12
Gros, D.13
Jordan, C.T.14
Gotlib, J.15
Hsi, E.D.16
Abo, A.17
-
61
-
-
84883730914
-
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
-
Krönke, J., Bullinger, L., Teleanu, V., Tschürtz, F., Gaidzik, V.I., Kühn, M.W.M., Rücker, F.G., Holzmann, K., Paschka, P., Kapp-Schwörer, S., Späth, D., Kindler, T., Schittenhelm, M., Krauter, J., Ganser, A., Göhring, G., Schlegelberger, B., Schlenk, R.F., Döhner, H. & Döhner, K. (2013) Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia. Blood, 122, 100-108.
-
(2013)
Blood
, vol.122
, pp. 100-108
-
-
Krönke, J.1
Bullinger, L.2
Teleanu, V.3
Tschürtz, F.4
Gaidzik, V.I.5
Kühn, M.W.M.6
Rücker, F.G.7
Holzmann, K.8
Paschka, P.9
Kapp-Schwörer, S.10
Späth, D.11
Kindler, T.12
Schittenhelm, M.13
Krauter, J.14
Ganser, A.15
Göhring, G.16
Schlegelberger, B.17
Schlenk, R.F.18
Döhner, H.19
Döhner, K.20
more..
-
62
-
-
78650171819
-
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes
-
Krug, U., Röllig, C., Koschmieder, A., Heinecke, A., Sauerland, M.-C., Schaich, M., Thiede, C., Kramer, M., Braess, J., Spiekermann, K., Haferlach, T., Haferlach, C., Koschmieder, S., Rohde, C., Serve, H., Wörmann, B., Hiddemann, W., Ehninger, G., Berdel, W.E., Büchner, T. & Müller-Tidaw, C. (2010) Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes. Lancet, 376, 2000-2008.
-
(2010)
Lancet
, vol.376
, pp. 2000-2008
-
-
Krug, U.1
Röllig, C.2
Koschmieder, A.3
Heinecke, A.4
Sauerland, M.-C.5
Schaich, M.6
Thiede, C.7
Kramer, M.8
Braess, J.9
Spiekermann, K.10
Haferlach, T.11
Haferlach, C.12
Koschmieder, S.13
Rohde, C.14
Serve, H.15
Wörmann, B.16
Hiddemann, W.17
Ehninger, G.18
Berdel, W.E.19
Büchner, T.20
Müller-Tidaw, C.21
more..
-
63
-
-
84155172363
-
Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up
-
Larsen, H.Ø., Roug, A.S., Just, T., Brown, G.D. & Hokland, P. (2012) Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up. Cytometry Part B, Clinical Cytometry, 82, 3-8.
-
(2012)
Cytometry Part B, Clinical Cytometry
, vol.82
, pp. 3-8
-
-
Larsen, H.1
Roug, A.S.2
Just, T.3
Brown, G.D.4
Hokland, P.5
-
64
-
-
78649906060
-
DNMT3A mutations in acute myeloid leukemia
-
Ley, T.J., Ding, L., Walter, M.J., McLellan, M.D., Lamprecht, T., Larson, D.E., Kandoth, C., Payton, J.E., Baty, J., Welch, J., Harris, C.C., Lichti, C.F., Townsend, R.R., Fulton, R.S., Dooling, D.J., Koboldt, D.C., Schmidt, H., Zhang, Q., Osborne, J.R., Lin, L., O'Laughlin, M., McMichael, J.F., Delehaunty, K.D., McGrath, S.D., Fulton, L.A., Magrini, V.J., Vickery, T.L., Hundal, J., Cook, L.L., Conyers, J.J., Swift, G.W., Reed, J.P., Alldredge, P.A., Wylie, T., Walker, J., Kalicki, J., Watson, M.A., Heath, S., Shannon, W.D., Varghese, N., Nagarajan, R., Westervelt, P., Tomasson, M.H., Link, D.C., Graubert, T.A., DiPersio, J.F., Mardis, E.R. & Wilson, R.K. (2010) DNMT3A mutations in acute myeloid leukemia. The New England Journal of Medicine, 363, 2424-2433.
-
(2010)
The New England Journal of Medicine
, vol.363
, pp. 2424-2433
-
-
Ley, T.J.1
Ding, L.2
Walter, M.J.3
McLellan, M.D.4
Lamprecht, T.5
Larson, D.E.6
Kandoth, C.7
Payton, J.E.8
Baty, J.9
Welch, J.10
Harris, C.C.11
Lichti, C.F.12
Townsend, R.R.13
Fulton, R.S.14
Dooling, D.J.15
Koboldt, D.C.16
Schmidt, H.17
Zhang, Q.18
Osborne, J.R.19
Lin, L.20
O'Laughlin, M.21
McMichael, J.F.22
Delehaunty, K.D.23
McGrath, S.D.24
Fulton, L.A.25
Magrini, V.J.26
Vickery, T.L.27
Hundal, J.28
Cook, L.L.29
Conyers, J.J.30
Swift, G.W.31
Reed, J.P.32
Alldredge, P.A.33
Wylie, T.34
Walker, J.35
Kalicki, J.36
Watson, M.A.37
Heath, S.38
Shannon, W.D.39
Varghese, N.40
Nagarajan, R.41
Westervelt, P.42
Tomasson, M.H.43
Link, D.C.44
Graubert, T.A.45
DiPersio, J.F.46
Mardis, E.R.47
Wilson, R.K.48
more..
-
65
-
-
84875999131
-
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study
-
Li, Z., Herold, T., He, C., Valk, P.J.M., Chen, P., Jurinovic, V., Mansmann, U., Radmacher, M.D., Maharry, K.S., Sun, M., Yang, X., Huang, H., Jiang, X., Sauerland, M.-C., Büchner, T., Hiddemann, W., Elkahloun, A., Neilly, M.B., Zhang, Y., Larson, R.A., Le Beau, M.M., Caligiuri, M.A., Döhner, K., Bullinger, L., Liu, P.P., Delwel, R., Marcucci, G., Löwenberg, B., Bloomfield, C.D., Rowley, J.D., Bohlander, S.K. & Chen, J. (2013) Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. Journal of Clinical Oncology, 31, 1172-1181.
-
(2013)
Journal of Clinical Oncology
, vol.31
, pp. 1172-1181
-
-
Li, Z.1
Herold, T.2
He, C.3
Valk, P.J.M.4
Chen, P.5
Jurinovic, V.6
Mansmann, U.7
Radmacher, M.D.8
Maharry, K.S.9
Sun, M.10
Yang, X.11
Huang, H.12
Jiang, X.13
Sauerland, M.-C.14
Büchner, T.15
Hiddemann, W.16
Elkahloun, A.17
Neilly, M.B.18
Zhang, Y.19
Larson, R.A.20
Le Beau, M.M.21
Caligiuri, M.A.22
Döhner, K.23
Bullinger, L.24
Liu, P.P.25
Delwel, R.26
Marcucci, G.27
Löwenberg, B.28
Bloomfield, C.D.29
Rowley, J.D.30
Bohlander, S.K.31
Chen, J.32
more..
-
66
-
-
84896028589
-
Prognostic factors for acute myeloid leukaemia in adults - biological significance and clinical use
-
Liersch, R., Müller-Tidow, C., Berdel, W.E. & Krug, U. (2014) Prognostic factors for acute myeloid leukaemia in adults - biological significance and clinical use. British Journal of Haematology, 165, 17-38.
-
(2014)
British Journal of Haematology
, vol.165
, pp. 17-38
-
-
Liersch, R.1
Müller-Tidow, C.2
Berdel, W.E.3
Krug, U.4
-
67
-
-
1942442136
-
Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice
-
Lock, R.J., Virgo, P.F., Kitchen, C. & Evely, R.S. (2004) Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice. Clinical and Laboratory Haematology, 26, 101-106.
-
(2004)
Clinical and Laboratory Haematology
, vol.26
, pp. 101-106
-
-
Lock, R.J.1
Virgo, P.F.2
Kitchen, C.3
Evely, R.S.4
-
68
-
-
84895770396
-
Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring
-
Luthra, R., Patel, K.P., Reddy, N.G., Haghshenas, V., Routbort, M.J., Harmon, M.A., Barkoh, B.A., Kanagal-Shamanna, R., Ravandi, F., Cortes, J.E., Kantarjian, H.M., Medeiros, L.J. & Singh, R.R. (2014) Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring. Haematologica, 99, 465-473.
-
(2014)
Haematologica
, vol.99
, pp. 465-473
-
-
Luthra, R.1
Patel, K.P.2
Reddy, N.G.3
Haghshenas, V.4
Routbort, M.J.5
Harmon, M.A.6
Barkoh, B.A.7
Kanagal-Shamanna, R.8
Ravandi, F.9
Cortes, J.E.10
Kantarjian, H.M.11
Medeiros, L.J.12
Singh, R.R.13
-
69
-
-
67650632683
-
CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
-
Majeti, R., Chao, M.P., Alizadeh, A.A., Pang, W.W., Jaiswal, S., Gibbs, K.D., van Rooijen, N. & Weissman, I.L. (2009) CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 138, 286-299.
-
(2009)
Cell
, vol.138
, pp. 286-299
-
-
Majeti, R.1
Chao, M.P.2
Alizadeh, A.A.3
Pang, W.W.4
Jaiswal, S.5
Gibbs, K.D.6
van Rooijen, N.7
Weissman, I.L.8
-
70
-
-
84898679051
-
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score
-
Marcucci, G., Yan, P., Maharry, K., Frankhouser, D., Nicolet, D., Metzeler, K.H., Kohlschmidt, J., Mrózek, K., Wu, Y.-Z., Bucci, D., Curfman, J.P., Whitman, S.P., Eisfeld, A.-K., Mendler, J.H., Schwind, S., Becker, H., Bär, C., Carroll, A.J., Baer, M.R., Wetzler, M., Carter, T.H., Powell, B.L., Kolitz, J.E., Byrd, J.C., Plass, C., Garzon, R., Caligiuri, M.A., Stone, R.M., Volinia, S., Bundschuh, R. & Bloomfield, C.D. (2014) Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score. Journal of Clinical Oncology, 32, 548-556.
-
(2014)
Journal of Clinical Oncology
, vol.32
, pp. 548-556
-
-
Marcucci, G.1
Yan, P.2
Maharry, K.3
Frankhouser, D.4
Nicolet, D.5
Metzeler, K.H.6
Kohlschmidt, J.7
Mrózek, K.8
Wu, Y.-Z.9
Bucci, D.10
Curfman, J.P.11
Whitman, S.P.12
Eisfeld, A.-K.13
Mendler, J.H.14
Schwind, S.15
Becker, H.16
Bär, C.17
Carroll, A.J.18
Baer, M.R.19
Wetzler, M.20
Carter, T.H.21
Powell, B.L.22
Kolitz, J.E.23
Byrd, J.C.24
Plass, C.25
Garzon, R.26
Caligiuri, M.A.27
Stone, R.M.28
Volinia, S.29
Bundschuh, R.30
Bloomfield, C.D.31
more..
-
71
-
-
34447295435
-
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow
-
Maurillo, L., Buccisano, F., Spagnoli, A., Del Poeta, G., Panetta, P., Neri, B., Del Principe, M.I., Mazzone, C., Consalvo, M.I., Tamburini, A., Ottaviani, L., Fraboni, D., Sarlo, C., de Fabritiis, P., Amadori, S. & Venditti, A. (2007) Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow. Haematologica, 92, 605-611.
-
(2007)
Haematologica
, vol.92
, pp. 605-611
-
-
Maurillo, L.1
Buccisano, F.2
Spagnoli, A.3
Del Poeta, G.4
Panetta, P.5
Neri, B.6
Del Principe, M.I.7
Mazzone, C.8
Consalvo, M.I.9
Tamburini, A.10
Ottaviani, L.11
Fraboni, D.12
Sarlo, C.13
de Fabritiis, P.14
Amadori, S.15
Venditti, A.16
-
72
-
-
84891625028
-
Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia
-
Medeiros, B.C., Othus, M., Estey, E.H., Fang, M. & Appelbaum, F.R. (2014) Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia. British Journal of Haematology, 164, 245-250.
-
(2014)
British Journal of Haematology
, vol.164
, pp. 245-250
-
-
Medeiros, B.C.1
Othus, M.2
Estey, E.H.3
Fang, M.4
Appelbaum, F.R.5
-
73
-
-
84865720625
-
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures
-
Mendler, J.H., Maharry, K., Radmacher, M.D., Mrózek, K., Becker, H., Metzeler, K.H., Schwind, S., Whitman, S.P., Khalife, J., Kohlschmidt, J., Nicolet, D., Powell, B.L., Carter, T.H., Wetzler, M., Moore, J.O., Kolitz, J.E., Baer, M.R., Carroll, A.J., Larson, R.A., Caligiuri, M.A., Marcucci, G. & Bloomfield, C.D. (2012) RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures. Journal of Clinical Oncology, 30, 3109-3118.
-
(2012)
Journal of Clinical Oncology
, vol.30
, pp. 3109-3118
-
-
Mendler, J.H.1
Maharry, K.2
Radmacher, M.D.3
Mrózek, K.4
Becker, H.5
Metzeler, K.H.6
Schwind, S.7
Whitman, S.P.8
Khalife, J.9
Kohlschmidt, J.10
Nicolet, D.11
Powell, B.L.12
Carter, T.H.13
Wetzler, M.14
Moore, J.O.15
Kolitz, J.E.16
Baer, M.R.17
Carroll, A.J.18
Larson, R.A.19
Caligiuri, M.A.20
Marcucci, G.21
Bloomfield, C.D.22
more..
-
74
-
-
77955479205
-
Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer
-
Mitelman, F., Johansson, B. & Mertens, F. (eds) (2014). Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
-
(2014)
-
-
Mitelman, F.1
Johansson, B.2
Mertens, F.3
-
75
-
-
55549136382
-
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
-
Mufti, G.J., Bennett, J.M., Goasguen, J., Bain, B.J., Baumann, I., Brunning, R., Cazzola, M., Fenaux, P., Germing, U., Hellström-Lindberg, E., Jinnai, I., Manabe, A., Matsuda, A., Niemeyer, C.M., Sanz, G., Tomonaga, M., Vallespi, T. & Yoshimi, A. (2008) Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica, 93, 1712-1717.
-
(2008)
Haematologica
, vol.93
, pp. 1712-1717
-
-
Mufti, G.J.1
Bennett, J.M.2
Goasguen, J.3
Bain, B.J.4
Baumann, I.5
Brunning, R.6
Cazzola, M.7
Fenaux, P.8
Germing, U.9
Hellström-Lindberg, E.10
Jinnai, I.11
Manabe, A.12
Matsuda, A.13
Niemeyer, C.M.14
Sanz, G.15
Tomonaga, M.16
Vallespi, T.17
Yoshimi, A.18
-
76
-
-
0020396015
-
Toxicity and response criteria of the Eastern Cooperative Oncology Group
-
Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T. & Carbone, P.P. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655.
-
(1982)
American Journal of Clinical Oncology
, vol.5
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
Horton, J.4
Davis, T.E.5
McFadden, E.T.6
Carbone, P.P.7
-
77
-
-
38349053347
-
Multiparametric analysis of normal and postchemotherapy bone marrow: implication for the detection of leukemia-associated immunophenotypes
-
Olaru, D., Campos, L., Flandrin, P., Nadal, N., Duval, A., Chautard, S. & Guyotat, D. (2008) Multiparametric analysis of normal and postchemotherapy bone marrow: implication for the detection of leukemia-associated immunophenotypes. Cytometry Part B, Clinical Cytometry, 74, 17-24.
-
(2008)
Cytometry Part B, Clinical Cytometry
, vol.74
, pp. 17-24
-
-
Olaru, D.1
Campos, L.2
Flandrin, P.3
Nadal, N.4
Duval, A.5
Chautard, S.6
Guyotat, D.7
-
78
-
-
75649091203
-
Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias
-
Ommen, H.B., Schnittger, S., Jovanovic, J.V., Ommen, I.B., Hasle, H., Østergaard, M., Grimwade, D. & Hokland, P. (2010) Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias. Blood, 115, 198-205.
-
(2010)
Blood
, vol.115
, pp. 198-205
-
-
Ommen, H.B.1
Schnittger, S.2
Jovanovic, J.V.3
Ommen, I.B.4
Hasle, H.5
Østergaard, M.6
Grimwade, D.7
Hokland, P.8
-
79
-
-
84877930147
-
MRD in AML: time for redefinition of CR?
-
Ossenkoppele, G. & Schuurhuis, G.J. (2013) MRD in AML: time for redefinition of CR? Blood, 121, 2166-2168.
-
(2013)
Blood
, vol.121
, pp. 2166-2168
-
-
Ossenkoppele, G.1
Schuurhuis, G.J.2
-
80
-
-
79955015676
-
Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms
-
Ossenkoppele, G.J., van de Loosdrecht, A.A. & Schuurhuis, G.J. (2011) Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms. British Journal of Haematology, 153, 421-436.
-
(2011)
British Journal of Haematology
, vol.153
, pp. 421-436
-
-
Ossenkoppele, G.J.1
van de Loosdrecht, A.A.2
Schuurhuis, G.J.3
-
81
-
-
84876798097
-
Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin
-
Ottone, T., Zaza, S., Divona, M., Hasan, S.K., Lavorgna, S., Laterza, S., Cicconi, L., Panetta, P., Di Giandomenico, J., Cittadini, M., Ciardi, C., Montefusco, E., Franchi, A., Annino, L., Venditti, A., Amadori, S. & Lo-Coco, F. (2013) Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin. British Journal of Haematology, 161, 533-540.
-
(2013)
British Journal of Haematology
, vol.161
, pp. 533-540
-
-
Ottone, T.1
Zaza, S.2
Divona, M.3
Hasan, S.K.4
Lavorgna, S.5
Laterza, S.6
Cicconi, L.7
Panetta, P.8
Di Giandomenico, J.9
Cittadini, M.10
Ciardi, C.11
Montefusco, E.12
Franchi, A.13
Annino, L.14
Venditti, A.15
Amadori, S.16
Lo-Coco, F.17
-
82
-
-
84879350221
-
Minimal residual disease in acute myeloid leukemia: coming of age. Education Program of the American Society of Hematology
-
Paietta, E. (2012) Minimal residual disease in acute myeloid leukemia: coming of age. Education Program of the American Society of Hematology. American Society of Hematology Education Program, 2012, 35-42.
-
(2012)
American Society of Hematology Education Program
, vol.2012
, pp. 35-42
-
-
Paietta, E.1
-
83
-
-
77955907891
-
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication
-
Paschka, P., Schlenk, R.F., Gaidzik, V.I., Habdank, M., Krönke, J., Bullinger, L., Späth, D., Kayser, S., Zucknick, M., Götze, K., Horst, H.-A., Germing, U., Döhner, H. & Döhner, K. (2010) IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. Journal of Clinical Oncology, 28, 3636-3643.
-
(2010)
Journal of Clinical Oncology
, vol.28
, pp. 3636-3643
-
-
Paschka, P.1
Schlenk, R.F.2
Gaidzik, V.I.3
Habdank, M.4
Krönke, J.5
Bullinger, L.6
Späth, D.7
Kayser, S.8
Zucknick, M.9
Götze, K.10
Horst, H.-A.11
Germing, U.12
Döhner, H.13
Döhner, K.14
-
84
-
-
84863393263
-
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
-
Patel, J.P., Gönen, M., Figueroa, M.E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., Huberman, K., Cheng, J., Viale, A., Socci, N.D., Heguy, A., Cherry, A., Vance, G., Higgins, R.R., Ketterling, R.P., Gallagher, R.E., Litzow, M., van den Brink, M.R.M., Lazarus, H.M., Rowe, J.M., Luger, S., Ferrando, A., Paietta, E., Tallman, M.S., Melnick, A., Abdel-Wahab, O. & Levine, R.L. (2012) Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. The New England Journal of Medicine, 366, 1079-1089.
-
(2012)
The New England Journal of Medicine
, vol.366
, pp. 1079-1089
-
-
Patel, J.P.1
Gönen, M.2
Figueroa, M.E.3
Fernandez, H.4
Sun, Z.5
Racevskis, J.6
Van Vlierberghe, P.7
Dolgalev, I.8
Thomas, S.9
Aminova, O.10
Huberman, K.11
Cheng, J.12
Viale, A.13
Socci, N.D.14
Heguy, A.15
Cherry, A.16
Vance, G.17
Higgins, R.R.18
Ketterling, R.P.19
Gallagher, R.E.20
Litzow, M.21
van den Brink, M.R.M.22
Lazarus, H.M.23
Rowe, J.M.24
Luger, S.25
Ferrando, A.26
Paietta, E.27
Tallman, M.S.28
Melnick, A.29
Abdel-Wahab, O.30
Levine, R.L.31
more..
-
85
-
-
84878344487
-
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy
-
Pratcorona, M., Brunet, S., Nomdedeu, J., Ribera, J.M., Tormo, M., Duarte, R., Escoda, L., Guàrdia, R., de Queipo Llano, M.P., Salamero, O., Bargay, J., Pedro, C., Martí, J.M., Torrebadell, M., Díaz-Beyá, M., Camós, M., Colomer, D., Hoyos, M., Sierra, J. & Esteve, J.; Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas (2013) Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy. Blood, 121, 2734-2738.
-
(2013)
Blood
, vol.121
, pp. 2734-2738
-
-
Pratcorona, M.1
Brunet, S.2
Nomdedeu, J.3
Ribera, J.M.4
Tormo, M.5
Duarte, R.6
Escoda, L.7
Guàrdia, R.8
de Queipo Llano, M.P.9
Salamero, O.10
Bargay, J.11
Pedro, C.12
Martí, J.M.13
Torrebadell, M.14
Díaz-Beyá, M.15
Camós, M.16
Colomer, D.17
Hoyos, M.18
Sierra, J.19
Esteve, J.20
more..
-
86
-
-
34447646569
-
Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission
-
van Rhenen, A., Moshaver, B., Kelder, A., Feller, N., Nieuwint, A.W.M., Zweegman, S., Ossenkoppele, G.J. & Schuurhuis, G.J. (2007) Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. Leukemia, 21, 1700-1707.
-
(2007)
Leukemia
, vol.21
, pp. 1700-1707
-
-
van Rhenen, A.1
Moshaver, B.2
Kelder, A.3
Feller, N.4
Nieuwint, A.W.M.5
Zweegman, S.6
Ossenkoppele, G.J.7
Schuurhuis, G.J.8
-
87
-
-
84862502902
-
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
-
Ribeiro, A.F.T., Pratcorona, M., Erpelinck-Verschueren, C., Rockova, V., Sanders, M., Abbas, S., Figueroa, M.E., Zeilemaker, A., Melnick, A., Löwenberg, B., Valk, P.J.M. & Delwel, R. (2012) Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood, 119, 5824-5831.
-
(2012)
Blood
, vol.119
, pp. 5824-5831
-
-
Ribeiro, A.F.T.1
Pratcorona, M.2
Erpelinck-Verschueren, C.3
Rockova, V.4
Sanders, M.5
Abbas, S.6
Figueroa, M.E.7
Zeilemaker, A.8
Melnick, A.9
Löwenberg, B.10
Valk, P.J.M.11
Delwel, R.12
-
88
-
-
84891624172
-
hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia
-
Roug, A.S., Larsen, H.Ø., Nederby, L., Just, T., Brown, G., Nyvold, C.G., Ommen, H.B. & Hokland, P. (2013) hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia. British Journal of Haematology, 164, 212-222.
-
(2013)
British Journal of Haematology
, vol.164
, pp. 212-222
-
-
Roug, A.S.1
Larsen, H.2
Nederby, L.3
Just, T.4
Brown, G.5
Nyvold, C.G.6
Ommen, H.B.7
Hokland, P.8
-
89
-
-
84857734093
-
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
-
Rücker, F.G., Schlenk, R.F., Bullinger, L., Kayser, S., Teleanu, V., Kett, H., Habdank, M., Kugler, C.-M., Holzmann, K., Gaidzik, V.I., Paschka, P., Held, G., von Lilienfeld-Toal, M., Lübbert, M., Fröhling, S., Zenz, T., Krauter, J., Schlegelberger, B., Ganser, A., Lichter, P., Döhner, K. & Döhner, H. (2012) TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood, 119, 2114-2121.
-
(2012)
Blood
, vol.119
, pp. 2114-2121
-
-
Rücker, F.G.1
Schlenk, R.F.2
Bullinger, L.3
Kayser, S.4
Teleanu, V.5
Kett, H.6
Habdank, M.7
Kugler, C.-M.8
Holzmann, K.9
Gaidzik, V.I.10
Paschka, P.11
Held, G.12
von Lilienfeld-Toal, M.13
Lübbert, M.14
Fröhling, S.15
Zenz, T.16
Krauter, J.17
Schlegelberger, B.18
Ganser, A.19
Lichter, P.20
Döhner, K.21
Döhner, H.22
more..
-
90
-
-
77950565905
-
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
-
Santamaría, C., Chillón, M.C., García-Sanz, R., Pérez, C., Caballero, M.D., Mateos, M.V., Ramos, F., de Coca, A.G., Alonso, J.M., Giraldo, P., Bernal, T., Queizán, J.A., Rodríguez, J.N., Puig, N., Balanzategui, A., Sarasquete, M.E., Alcoceba, M., Díaz-Mediavilla, J., San Miguel, J. & González, M. (2010) BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML). Annals of Hematology, 89, 453-458.
-
(2010)
Annals of Hematology
, vol.89
, pp. 453-458
-
-
Santamaría, C.1
Chillón, M.C.2
García-Sanz, R.3
Pérez, C.4
Caballero, M.D.5
Mateos, M.V.6
Ramos, F.7
de Coca, A.G.8
Alonso, J.M.9
Giraldo, P.10
Bernal, T.11
Queizán, J.A.12
Rodríguez, J.N.13
Puig, N.14
Balanzategui, A.15
Sarasquete, M.E.16
Alcoceba, M.17
Díaz-Mediavilla, J.18
San Miguel, J.19
González, M.20
more..
-
91
-
-
79955508307
-
Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia
-
Santos, F.P.S., Jones, D., Qiao, W., Cortes, J.E., Ravandi, F., Estey, E.E., Verma, D., Kantarjian, H. & Borthakur, G. (2011) Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia. Cancer, 117, 2145-2155.
-
(2011)
Cancer
, vol.117
, pp. 2145-2155
-
-
Santos, F.P.S.1
Jones, D.2
Qiao, W.3
Cortes, J.E.4
Ravandi, F.5
Estey, E.E.6
Verma, D.7
Kantarjian, H.8
Borthakur, G.9
-
92
-
-
70349579540
-
Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
-
Schnittger, S., Kern, W., Tschulik, C., Weiss, T., Dicker, F., Falini, B., Haferlach, C. & Haferlach, T. (2009) Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML. Blood, 114, 2220-2231.
-
(2009)
Blood
, vol.114
, pp. 2220-2231
-
-
Schnittger, S.1
Kern, W.2
Tschulik, C.3
Weiss, T.4
Dicker, F.5
Falini, B.6
Haferlach, C.7
Haferlach, T.8
-
93
-
-
84873568769
-
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome
-
Schnittger, S., Eder, C., Jeromin, S., Alpermann, T., Fasan, A., Grossmann, V., Kohlmann, A., Illig, T., Klopp, N., Wichmann, H.-E., Kreuzer, K.-A., Schmid, C., Staib, P., Peceny, R., Schmitz, N., Kern, W., Haferlach, C. & Haferlach, T. (2013) ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia, 27, 82-91.
-
(2013)
Leukemia
, vol.27
, pp. 82-91
-
-
Schnittger, S.1
Eder, C.2
Jeromin, S.3
Alpermann, T.4
Fasan, A.5
Grossmann, V.6
Kohlmann, A.7
Illig, T.8
Klopp, N.9
Wichmann, H.-E.10
Kreuzer, K.-A.11
Schmid, C.12
Staib, P.13
Peceny, R.14
Schmitz, N.15
Kern, W.16
Haferlach, C.17
Haferlach, T.18
-
94
-
-
74049146227
-
Minimal residual disease quantitation in acute myeloid leukemia
-
Shook, D., Coustan-Smith, E., Ribeiro, R.C., Rubnitz, J.E. & Campana, D. (2009) Minimal residual disease quantitation in acute myeloid leukemia. Clinical Lymphoma & Myeloma, 9(Suppl 3), 281-285.
-
(2009)
Clinical Lymphoma & Myeloma
, vol.9
, pp. 281-285
-
-
Shook, D.1
Coustan-Smith, E.2
Ribeiro, R.C.3
Rubnitz, J.E.4
Campana, D.5
-
95
-
-
53249123632
-
-
IARC Press, Lyon, France.
-
Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
-
-
Swerdlow, S.H.1
Campo, E.2
Harris, N.L.3
Jaffe, E.S.4
Pileri, S.A.5
Stein, H.6
Thiele, J.7
Vardiman, J.W.8
-
96
-
-
84882490310
-
Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia
-
Tallman, M.S., Lo-Coco, F., Kwaan, H.C., Sanz, M.A. & Gore, S.D. (2011) Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia. Clinical Advances in Hematology and Oncology, 9, 1-16.
-
(2011)
Clinical Advances in Hematology and Oncology
, vol.9
, pp. 1-16
-
-
Tallman, M.S.1
Lo-Coco, F.2
Kwaan, H.C.3
Sanz, M.A.4
Gore, S.D.5
-
97
-
-
66149095813
-
Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML
-
Terwijn, M., Feller, N., van Rhenen, A., Kelder, A., Westra, G., Zweegman, S., Ossenkoppele, G. & Schuurhuis, G. (2009) Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML. European Journal of Cancer, 45, 1692-1699.
-
(2009)
European Journal of Cancer
, vol.45
, pp. 1692-1699
-
-
Terwijn, M.1
Feller, N.2
van Rhenen, A.3
Kelder, A.4
Westra, G.5
Zweegman, S.6
Ossenkoppele, G.7
Schuurhuis, G.8
-
98
-
-
33646557337
-
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
-
Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M. & Ehninger, G. (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood, 107, 4011-4020.
-
(2006)
Blood
, vol.107
, pp. 4011-4020
-
-
Thiede, C.1
Koch, S.2
Creutzig, E.3
Steudel, C.4
Illmer, T.5
Schaich, M.6
Ehninger, G.7
-
99
-
-
78951476130
-
Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept
-
Valent, P. (2011) Targeting of leukemia-initiating cells to develop curative drug therapies: straightforward but nontrivial concept. Current Cancer Drug Targets, 11, 56-71.
-
(2011)
Current Cancer Drug Targets
, vol.11
, pp. 56-71
-
-
Valent, P.1
-
100
-
-
70349256226
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
-
Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., Harris, N.L., Le Beau, M.M., Hellström-Lindberg, E., Tefferi, A. & Bloomfield, C.D. (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, 114, 937-951.
-
(2009)
Blood
, vol.114
, pp. 937-951
-
-
Vardiman, J.W.1
Thiele, J.2
Arber, D.A.3
Brunning, R.D.4
Borowitz, M.J.5
Porwit, A.6
Harris, N.L.7
Le Beau, M.M.8
Hellström-Lindberg, E.9
Tefferi, A.10
Bloomfield, C.D.11
-
101
-
-
84856005158
-
Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases
-
Veigaard, C., Nørgaard, J.M. & Kjeldsen, E. (2011) Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases. Cancer Genetics, 204, 516-521.
-
(2011)
Cancer Genetics
, vol.204
, pp. 516-521
-
-
Veigaard, C.1
Nørgaard, J.M.2
Kjeldsen, E.3
-
102
-
-
7744244145
-
Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings
-
Voskova, D., Schoch, C., Schnittger, S., Hiddemann, W., Haferlach, T. & Kern, W. (2004) Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings. Cytometry Part B, Clinical Cytometry, 62, 25-38.
-
(2004)
Cytometry Part B, Clinical Cytometry
, vol.62
, pp. 25-38
-
-
Voskova, D.1
Schoch, C.2
Schnittger, S.3
Hiddemann, W.4
Haferlach, T.5
Kern, W.6
-
103
-
-
80052493235
-
Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia
-
Wakita, S., Yamaguchi, H., Miyake, K., Mitamura, Y., Kosaka, F., Dan, K. & Inokuchi, K. (2011) Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia. Leukemia, 25, 1423-1432.
-
(2011)
Leukemia
, vol.25
, pp. 1423-1432
-
-
Wakita, S.1
Yamaguchi, H.2
Miyake, K.3
Mitamura, Y.4
Kosaka, F.5
Dan, K.6
Inokuchi, K.7
-
104
-
-
81255175041
-
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
-
Walter, R.B., Othus, M., Borthakur, G., Ravandi, F., Cortes, J.E., Pierce, S.A., Appelbaum, F.R., Kantarjian, H.A. & Estey, E.H. (2011) Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. Journal of Clinical Oncology, 29, 4417-4423.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 4417-4423
-
-
Walter, R.B.1
Othus, M.2
Borthakur, G.3
Ravandi, F.4
Cortes, J.E.5
Pierce, S.A.6
Appelbaum, F.R.7
Kantarjian, H.A.8
Estey, E.H.9
-
105
-
-
84876260322
-
EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia
-
Wang, X., Dai, H., Wang, Q., Wang, Q., Xu, Y., Wang, Y., Sun, A., Ruan, J., Chen, S. & Wu, D. (2013) EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia. PLoS ONE, 8, e61341.
-
(2013)
PLoS ONE
, vol.8
, pp. e61341
-
-
Wang, X.1
Dai, H.2
Wang, Q.3
Wang, Q.4
Xu, Y.5
Wang, Y.6
Sun, A.7
Ruan, J.8
Chen, S.9
Wu, D.10
-
106
-
-
84892416503
-
BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia
-
Weber, S., Alpermann, T., Dicker, F., Jeromin, S., Nadarajah, N., Eder, C., Fasan, A., Kohlmann, A., Meggendorfer, M., Haferlach, C., Kern, W., Haferlach, T. & Schnittger, S. (2014) BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia. Blood Cancer Journal, 4, e173.
-
(2014)
Blood Cancer Journal
, vol.4
, pp. e173
-
-
Weber, S.1
Alpermann, T.2
Dicker, F.3
Jeromin, S.4
Nadarajah, N.5
Eder, C.6
Fasan, A.7
Kohlmann, A.8
Meggendorfer, M.9
Haferlach, C.10
Kern, W.11
Haferlach, T.12
Schnittger, S.13
-
107
-
-
84860703461
-
Landscape of TET2 mutations in acute myeloid leukemia
-
Weissmann, S., Alpermann, T., Grossmann, V., Kowarsch, A., Nadarajah, N., Eder, C., Dicker, F., Fasan, A., Haferlach, C., Haferlach, T., Kern, W., Schnittger, S. & Kohlmann, A. (2012) Landscape of TET2 mutations in acute myeloid leukemia. Leukemia, 26, 934-942.
-
(2012)
Leukemia
, vol.26
, pp. 934-942
-
-
Weissmann, S.1
Alpermann, T.2
Grossmann, V.3
Kowarsch, A.4
Nadarajah, N.5
Eder, C.6
Dicker, F.7
Fasan, A.8
Haferlach, C.9
Haferlach, T.10
Kern, W.11
Schnittger, S.12
Kohlmann, A.13
-
108
-
-
84898045456
-
Genomic tools in acute myeloid leukemia: from the bench to the bedside
-
White, B.S. & DiPersio, J.F. (2014) Genomic tools in acute myeloid leukemia: from the bench to the bedside. Cancer, 120, 1134-1144.
-
(2014)
Cancer
, vol.120
, pp. 1134-1144
-
-
White, B.S.1
DiPersio, J.F.2
-
109
-
-
84896942225
-
Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review
-
Zeichner, S.B., Alghamdi, S., Elhammady, G. & Poppiti, R.J. (2014) Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review. Asian Pacific Journal of Cancer Prevention, 15, 1603-1609.
-
(2014)
Asian Pacific Journal of Cancer Prevention
, vol.15
, pp. 1603-1609
-
-
Zeichner, S.B.1
Alghamdi, S.2
Elhammady, G.3
Poppiti, R.J.4
-
110
-
-
84890546828
-
Tumor heterogeneity makes AML a 'moving target' for detection of residual disease
-
Zeijlemaker, W., Gratama, J.W. & Schuurhuis, G.J. (2014) Tumor heterogeneity makes AML a 'moving target' for detection of residual disease. Cytometry Part B, Clinical Cytometry, 86, 3-14.
-
(2014)
Cytometry Part B, Clinical Cytometry
, vol.86
, pp. 3-14
-
-
Zeijlemaker, W.1
Gratama, J.W.2
Schuurhuis, G.J.3
-
111
-
-
67650367598
-
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
-
Zeng, Z., Shi, Y.X., Samudio, I.J., Wang, R.-Y., Ling, X., Frolova, O., Levis, M., Rubin, J.B., Negrin, R.R., Estey, E.H., Konoplev, S., Andreeff, M. & Konopleva, M. (2009) Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood, 113, 6215-6224.
-
(2009)
Blood
, vol.113
, pp. 6215-6224
-
-
Zeng, Z.1
Shi, Y.X.2
Samudio, I.J.3
Wang, R.-Y.4
Ling, X.5
Frolova, O.6
Levis, M.7
Rubin, J.B.8
Negrin, R.R.9
Estey, E.H.10
Konoplev, S.11
Andreeff, M.12
Konopleva, M.13
-
112
-
-
84868342138
-
Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis
-
Zhou, K.-G., Jiang, L.-J., Shang, Z., Wang, J., Huang, L. & Zhou, J.-F. (2012) Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis. Leukemia & Lymphoma, 53, 2423-2429.
-
(2012)
Leukemia & Lymphoma
, vol.53
, pp. 2423-2429
-
-
Zhou, K.-G.1
Jiang, L.-J.2
Shang, Z.3
Wang, J.4
Huang, L.5
Zhou, J.-F.6
|